Article
Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival.
International journal of cancer - 22 Oct 1999
Edwards S M, Badzioch M D, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R, Easton D F, Saunders G F, Dearnaley D P, Eeles R A
Abstract excerpt
Several reports have suggested that one or both of the trinucleotide repeat polymorphisms in the human androgen receptor (hAR) gene, (CAG)n coding for polyglutamine and (GGC)n coding for polyglycine, may be associated with prostate cancer risk; but no study has investigated their association with disease progression. We present here a study of both hAR trinucleotide repeat polymorphisms not only as they relate to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
